Eriksson A

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Tesi B, Robelius A, Baskin B, ..., Hellström-Lindberg E, Baliakas P

Clin. Cancer Res. 31 (14) 3062-3071 [2025-07-15; online 2025-05-19]

Clinical Genomics [Collaborative] Clinical Genomics Lund [Service] Clinical Genomics Uppsala [Collaborative]

A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in Caenorhabditis elegans.

Gorgoń S, Billing O, Eriksson AU, Hemmingsson O

Cancer Res Commun 4 (9) 2454-2462 [2024-09-01; online 2024-08-31]

Chemical Biology Consortium Sweden [Collaborative]

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Eriksson A, Engvall M, Mathot L, ..., Ladenvall C, Baliakas P

Clin. Cancer Res. 29 (15) 2826-2834 [2023-08-01; online 2023-04-07]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Collaborative] Clinical Genomics Uppsala [Collaborative] NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children.

Stratmann S, Vesterlund M, Umer HM, ..., Lehtiö J, Holmfeldt L

Leukemia 37 (3) 550-559 [2023-03-00; online 2022-12-26]

Bioinformatics Support for Computational Resources [Service] Global Proteomics and Proteogenomics [Collaborative]